As the novel coronavirus pandemic paralyzed most non-emergency medical practices this spring, the dialysis business rolled ahead and in some cases grew.
Democracy Dies in Darkness
Business is booming for dialysis giant Fresenius. It took a bailout of at least $137 million anyway.
Half of the money the Trump administration gave dialysis companies was collected by a global firm headquartered in Germany with a robust balance sheet. It’s one of the bluntest examples yet of how the Department of Health and Human Services failed to direct taxpayer-supported bailout funds only to providers in crisis.
By Jordan Rau
and Rachana Pradhan
August 5, 2020 at 1:13 p.m. EDT